Bank of New York Mellon’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-52,930
Closed -$1.06M 4304
2013
Q3
$1.06M Sell
52,930
-42,194
-44% -$688K ﹤0.01% 3214
2013
Q2
$1.4M Buy
+95,124
New +$1.36M ﹤0.01% 2986

Bank of New York Mellon's ROCM Position: Q4 2013 in Review

Bank of New York Mellon sold out of ROCHESTER MEDICAL CORP (ROCM) in Q4 2013, closing a stake of 52,930 shares — an estimated $1.06M sold.

Bank of New York Mellon first reported a position in ROCM in Q2 2013 and held it in 2 quarters. The position peaked at $1.4M in Q2 2013. 0 funds tracked by Wall St. Rank hold ROCM as of Q4 2013.

  • Bank of New York Mellon reported no remaining ROCHESTER MEDICAL CORP position as of Q4 2013 after selling out during the quarter.
  • Bank of New York Mellon sold 52,930 ROCHESTER MEDICAL CORP shares in Q4 2013, an estimated $1.06M.
  • Bank of New York Mellon first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 2 quarters.
  • Bank of New York Mellon's ROCHESTER MEDICAL CORP position peaked at $1.4M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q4 2013.

Based on Bank of New York Mellon's 13F filing for Q4 2013, filed 12 Feb 2014.